Table 3. Salicylic acid content of transgenic eggplants after inoculation (μg.g⁻¹ fresh weight).

Lines	Generation	Time of treatment (d)
		0	2	4	6	8
EGT0–5	T0	2.83 ± 0.32b	2.15 ± 0.24B	1.57 ± 0.11B	0.74 ± 0.02B	0.28 ± 0.01B
EGT0–23	T0	2.72 ± 0.17b	2.07 ± 0.12B	1.61 ± 0.08B	0.81 ± 0.02B	0.23 ± 0.01B
EGT0–43	T0	2.64 ± 0.25b	2.13 ± 0.11B	1.57 ± 0.09B	0.94 ± 0.03B	0.31 ± 0.02B
EGT0–87	T0	2.55 ± 0.23b	1.95 ± 0.19B	1.41 ± 0.03B	0.73 ± 0.05B	0.25 ± 0.01B
EGT0–145	T0	2.87 ± 0.22b	2.34 ± 0.15B	1.54 ± 0.02B	0.85 ± 0.03B	0.36 ± 0.03B
EGT0–204	T0	2.91 ± 0.19b	2.04 ± 0.12B	1.46 ± 0.05B	0.76 ± 0.01B	0.18 ± 0.01B
EGT1–87	T1	2.87 ± 0.21b	2.15 ± 0.14B	1.71 ± 0.01B	0.81 ± 0.06B	0.22 ± 0.02B
EGT1–145	T1	2.81 ± 0.13b	2.06 ± 0.11B	1.63 ± 0.11B	0.75 ± 0.03B	0.27 ± 0.01B
EGT1–204	T1	2.68 ± 0.24b	1.93 ± 0.18B	1.33 ± 0.11B	0.67 ± 0.01B	0.21 ± 0.01B
E-31	CK1	4.76 ± 0.25a	6.68 ± 0.44 A	8.82 ± 0.39A	13.67 ± 0.87A	9.58 ± 0.75A
RNAi-1	T0	4.15 ± 0.34a	5.62 ± 0.39A	7.64 ± 0.63a	10.35 ± 0.84A	8.42 ± 0.61A
RNAi-2	T0	4.23 ± 0.26a	5.04 ± 0.19A	7.21 ± 0.58a	11.21 ± 0.89A	8.04 ± 0.52A
RNAi-3	T0	4.56 ± 0.41a	6.13 ± 0.24A	7.54 ± 0.47a	10.64 ± 0.93A	7.95 ± 0.66A
RNAi-4	T0	4.31 ± 0.35a	6.15 ± 0.44A	7.27 ± 0.62a	10.83 ± 0.59A	7.33 ± 0.59A
RNAi-5	T0	4.47 ± 0.32a	5.97 ± 0.43A	7.18 ± 0.49a	11.33 ± 0.67A	7.61 ± 0.45A
RNAi-1-1	T1	4.53 ± 0.32a	6.21 ± 0.29A	7.37 ± 0.53a	10.87 ± 0.88A	6.95 ± 0.55A
RNAi-2-1	T1	4.67 ± 0.27a	6.25 ± 0.35A	7.55 ± 0.53a	11.24 ± 0.25A	7.41 ± 0.51A
RNAi-3-1	T1	4.36 ± 0.24a	6.22 ± 0.33A	7.46 ± 0.54a	11.62 ± 0.37A	7.46 ± 0.61A
E-32	CK2	3.87 ± 0.29b	4.52 ± 0.31B	6.12 ± 0.54b	4.33 ± 0.23B	2.65 ± 0.25B

Error bars represent standard error. ab, AB, Significantly different from CK: ab, P < 0.05; AB, P < 0.01.